Celyad SA Financials
| CYAD Stock | EUR 0.71 0.06 7.79% |
Celyad |
Understanding current and past Celyad SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Celyad SA's financial statements are interrelated, with each one affecting the others. For example, an increase in Celyad SA's assets may result in an increase in income on the income statement.
Celyad SA Stock Summary
Celyad SA competes with Immolease Trust, EVS Broadcast, Home Invest, Retail Estates, and Vastned Retail. Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor-T cell-based therapies for the treatment of cancer. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. CELYAD ONCOLOGY operates under Biotechnology classification in Belgium and is traded on Brussels Stock Exchange. It employs 87 people.| Foreign Associate | USA |
| Instrument | Belgium Stock View All |
| Exchange | Euronext Brussels |
| ISIN | BE0974260896 |
| Business Address | Rue Edouard Belin |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.celyad.com |
| Phone | (32) 10 394 141 |
| Currency | EUR - Euro |
You should never invest in Celyad SA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Celyad Stock, because this is throwing your money away. Analyzing the key information contained in Celyad SA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Celyad SA Key Financial Ratios
There are many critical financial ratios that Celyad SA's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Celyad SA reports annually and quarterly.Celyad Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Celyad SA's current stock value. Our valuation model uses many indicators to compare Celyad SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Celyad SA competition to find correlations between indicators driving Celyad SA's intrinsic value. More Info.Celyad SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Celyad SA's earnings, one of the primary drivers of an investment's value.Celyad SA Systematic Risk
Celyad SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Celyad SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Celyad SA correlated with the market. If Beta is less than 0 Celyad SA generally moves in the opposite direction as compared to the market. If Celyad SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Celyad SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Celyad SA is generally in the same direction as the market. If Beta > 1 Celyad SA moves generally in the same direction as, but more than the movement of the benchmark.
Celyad SA December 18, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Celyad SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Celyad SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Celyad SA based on widely used predictive technical indicators. In general, we focus on analyzing Celyad Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Celyad SA's daily price indicators and compare them against related drivers.
| Downside Deviation | 9.83 | |||
| Information Ratio | 0.1734 | |||
| Maximum Drawdown | 114.08 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 16.67 |
Additional Tools for Celyad Stock Analysis
When running Celyad SA's price analysis, check to measure Celyad SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celyad SA is operating at the current time. Most of Celyad SA's value examination focuses on studying past and present price action to predict the probability of Celyad SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celyad SA's price. Additionally, you may evaluate how the addition of Celyad SA to your portfolios can decrease your overall portfolio volatility.